| Value | ₹1.17 Cr |
|---|
BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹8.25
- Market cap
- ₹44.28 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 21.1×Sector 26.8×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Indrayani Biotech Other Announcement
Indrayani Biotech Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indrayani Biotech Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 150.0% YoY
Indrayani Biotech Ltd reported revenue from operations of ₹37.7 Cr (+29.6% YoY) and net profit of ₹0.5 Cr (+150.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +150.0% YoY
Indrayani Biotech Merger & Restructuring
Indrayani Biotech sold shares of its subsidiary, Dindigul Farm Product Limited, to the open market. This divestment marks a reduction in the company's subsidiary holding.
Indrayani Biotech Board Meeting Date
Indrayani Biotech will hold a board meeting on October 7, 2026, to consider the company's unaudited financial results for the quarter ended June 30, 2026.
Indrayani Biotech Capital Structure Change
Indrayani Biotech announced its Rights Issue of up to 3.25 crore partly paid-up equity shares at ₹15 per share, aggregating to ₹48.79 Crore.
- Value
- ₹48.79 Cr
Other legal & regulatory announcements
All →HD Fire Protect Legal & Regulatory
HD Fire Protect received an MPCB refusal of Consent to Operate for its Jalgaon expansion sheds. Existing manufacturing operations continue, with no material impact anticipated.
Krishna Institute of Medical Sciences Legal & Regulatory
KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.
Pervasive Commodities Legal & Regulatory
BSE waived Rs.11.07 lakh in fines levied on Pervasive Commodities for board and committee composition non-compliance. The company now owes no fine, so the monetary impact is nil.
- Value
- ₹0.11 Cr
Cummins India Legal & Regulatory
Cummins India received a CGST order from the Jaipur Commissionerate demanding Rs 5.19 Crore IGST plus an equal penalty for FY2020-21 to 2023-24. The company is evaluating an appeal, and the impact is not yet quantified.
- Value
- ₹5.19 Cr
Accelya Solutions India Legal & Regulatory
Accelya received an EPFO order to deposit Rs. 2.73 Crore in provident fund dues. The company may appeal, saying its records were not duly considered.
- Value
- ₹2.73 Cr
Engineers India Legal & Regulatory
Engineers India's Board noted NSE and BSE fines totalling Rs.10,73,800 for Regulation 17(1) non-compliance. Waiver is sought; the government must appoint the missing independent directors.
- Value
- ₹0.11 Cr